A new study suggests that popular weight-loss drugs like Ozempic and Wegovy may significantly lower the risk of obesity-related cancers in adults without diabetes.

“I think people today would think it’s staggering but it doesn’t surprise us at all,” Swinburne obesity specialist adjunct professor Professor John Dixon told 3AW Breakfast.

Press PLAY to listen to the full discussion

Image: iStock